What it sells
Medication & support to beat opioid addiction from home
Business model breakdown
Buyer: who owns the budget?
UnverifiedPatients with opioid use disorder (self-pay or via insurer) and referrers.
Trigger: what makes them buy now?
Wanting private, stigma-free at-home buprenorphine/Suboxone treatment with fast access (seen in 1-3 days).
Workflow: what inputs become what output?
Free welcome call, online visits with a care team, Suboxone prescription sent to local pharmacy, 7-day support access.
Economics: what it saves and how it charges
Billed to insurance including select Medicaid plans; reports 79% retention at 180 days and NPS 97.
Distribution: how it reaches customers
Direct to patient online, insurance checker, referral portal for clinicians, state-by-state payer network.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2020 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.